US biotech firm Moderna will become the sixth company to supply a coronavirus vaccine candidate to the EU after European Commission President Ursula von der Leyen said a deal for 160 million doses has been reached.

“I am happy to announce that tomorrow we will approve a new contract to secure another Covid-19 vaccine,” von der Leyen said on Tuesday.

The deal will allow the EU to buy up to 160 million doses of the vaccine developed by Moderna.

Last week, the American company announced that its vaccine has shown 94.5 percent effectiveness in preventing Covid-19, according to the results of interim late-stage clinical trials. (RT)